Hyperglycemia and steroid tapering: finding the right approach

Steroid-induced hyperglycemia is a common challenge in patients receiving corticosteroids, especially during treatment for conditions like COPD. While this condition is usually short-term, it can complicate recovery and impact patient outcomes if not managed thoughtfully.

This case discusses practical strategies for managing blood sugar levels during steroid tapers, with insights from practitioners in internal medicine, endocrinology, and oncology.

If you have an opinion on how to manage steroid-induced hyperglycemia, log in or sign up to share it with our community and see the consensus.

Questions for consult 

 Consults

Key takeaways about treating steroid-induced hyperglycemia:

• Short-term spikes don’t always need aggressive treatment
  For brief steroid tapers, monitoring may be enough. A small bump in oral meds or a correction factor can help—and the effectiveness of sliding scales is highly debated.
  
• Insulin may not be worth the short-term complexity
  In those not already on insulin, starting it just to manage steroid-induced hyperglycemia for a few days may not be practical. Instead, consider modest adjustments to oral hypoglycemics or simply monitor glucose levels closely—especially if the steroid taper is brief and the hyperglycemia isn’t severe.
  
• Education is essential for safe self-management
  Patients should be taught how to recognize and respond to signs of hyperglycemia and hypoglycemia. Clear instructions—similar to sick day protocols—can empower them to manage short-term changes safely and confidently.
  

Internal Medicine

"It needs to be looked at on a case-by-case basis. Patients who are already on insulin (basal and premeal) can easily adjust regimen temporarily to accommodate the hyperglycemia on a short-term basis from steroids. There is probably the only group that would benefit from the short-term adjustment.

In others, having them take insulin to counter the glucose spikes and the education that goes along with it may not be worth considering it may only be needed for a few short days."

Internal Medicine

"If the patient is already on insulin and comfortable with dosing, I would increase prandial insulin dose by 10-20% and provide a sliding scale. If not on insulin, I might temporarily increase oral hypoglycemics or simply monitor if not dangerously high."

Endocrinology/Diabetes

"With steroids, the adjustment depends on whether the patient is using insulin or oral agent therapy. I would only initiate insulin therapy if oral agent therapy is not successful despite adjustments. Patient education, similar to sick day adjustment, is essential. Short-term sliding scale is generally not effective, but a correction factor may be appropriate."

Oncology/Hematology

"It is important to engage an endocrinologist and palliative care specialist to aid in the taper. It is safer to be hyper rather than hypoglycemic to avoid complications of syncope, seizures, or withdrawal complications of an Addisonian nature."

Nurse Practitioner

"This is patient-to-patient specific, based on the patient's type of diabetes, their current therapy, and their normal glucose levels. If it's a short-term taper or steroid burst, I think it's reasonable to monitor the glucose levels more closely at home and use an NPH sliding scale for the short-term. All of this includes extensive patient education in regards to signs and symptoms of hyper- and hypoglycemia, as well as explicit instructions on when and how to treat their numbers and symptoms."

To review all peer consults on how to manage steroid-induced hyperglycemia, or share your own approach, read the full case on Healthcasts.